Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity. Issue 2 (27th January 2020) - Moia, Riccardo; Boggio, Elena; Gigliotti, Luca; Crisà, Elena; De Paoli, Lorenzo; Margiotta Casaluci, Gloria; Rolla, Roberta; Patriarca, Andrea; Gaidano, Gianluca; Dianzani, Umberto; Bruna, Riccardo